PolyPeptide Group AG

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1,440

Website

www.polypeptide.com

Country

🇨🇭 Switzerland

Exchange

Swiss

Founded 1952Baar, SwitzerlandSubsidiary of Draupnir Holding B

PolyPeptide is a contract development and manufacturing company globally. It develops and manufactures synthetic peptides used as active pharmaceutical ingredients or intermediates in therapeutic products.

The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1, as well as generic peptides and peptides used in cosmetics, animal health, and medical devices development and analytical services.

The company serves academic, pharmaceutical, and biotech companies. Founded in 1952, PolyPeptide is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.

Key Stats

52-Week Range

Fr 20.10Fr 50.10

Beta1.04

Trailing P/EN/A

Forward P/E30.32

Trailing EPS-0.60

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceFr 38.97

RecommendationBuy

Recommendation Mean2.00

Recent SEC Filings

SEC filings for this ticker are not available yet.